HCA
KURA icon

Harbor Capital Advisors’s Kura Oncology KURA Stock Holding History

Harbor Capital Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Buy
57,776
+2,246
+4% +$21.2K 0.04% 476
2026
Q1 		$451K Buy
55,530
+9,920
+22% +$85.2K 0.04% 503
2025
Q4 		$474K Buy
45,610
+5,557
+14% +$58.3K 0.04% 498
2025
Q3 		$354K Sell
40,053
-6,960
-15% -$49.6K 0.03% 551
2025
Q2 		$271K Buy
47,013
+9,069
+24% +$55.6K 0.01% 584
2025
Q1 		$250K Sell
37,944
-11,427
-23% -$89K 0.01% 598
2024
Q4 		$430K Buy
49,371
+2,076
+4% +$29.9K 0.02% 581
2024
Q3 		$924K Buy
47,295
+8,505
+22% +$172K 0.04% 471
2024
Q2 		$799K Buy
38,790
+7,899
+26% +$162K 0.06% 409
2024
Q1 		$659K Buy
+30,891
New +$601K 0.09% 311

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Harbor Capital Advisors's KURA Position: Q2 2026 in Review

Harbor Capital Advisors increased its Kura Oncology (KURA) stake by 4% in Q2 2026, buying an estimated $21.2K and bringing the position to 57,776 shares worth $634K. The position accounts for 0.04% of the portfolio, ranked #476.

Harbor Capital Advisors first reported a position in KURA in Q1 2024 and has held it in 10 quarters since. The position peaked at $924K in Q3 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Harbor Capital Advisors held 57,776 shares of Kura Oncology worth $634K as of Q2 2026.
  • Harbor Capital Advisors bought 2,246 Kura Oncology shares in Q2 2026, an estimated $21.2K.
  • Kura Oncology made up 0.04% of Harbor Capital Advisors's portfolio in Q2 2026, its #476 holding.
  • Harbor Capital Advisors first reported a position in Kura Oncology in Q1 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's Kura Oncology position peaked at $924K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.